Mehdi Nouraie
Papers
1
Total Citations
27
H-Index
1
About
Dr. Mehdi Nouraie is a leading translational researcher whose work bridges hematology, pulmonary medicine, and genomics, with a focus on sickle cell disease and pulmonary hypertension. His key contributions include the discovery of novel inducers of fetal globin through high-throughput screening, a breakthrough with therapeutic potential for beta-hemoglobinopathies. This work, published in *PLOS ONE* (2015, 27 citations), demonstrated that identified compounds are active in vivo in anemic baboons and transgenic mice, offering a path toward safe, orally bioavailable treatments. Dr. Nouraie’s research has significantly advanced understanding of the genetic and molecular mechanisms underlying sickle cell disease complications, particularly pulmonary hypertension. His studies have been widely cited, reflecting their impact on both basic science and clinical applications. Through collaborative efforts, he has helped identify biomarkers and therapeutic targets that improve patient outcomes. Dr. Nouraie’s work is notable for its integration of high-throughput screening with in vivo validation, showcasing his ability to translate bench discoveries into clinically relevant interventions. His ongoing research continues to shape the landscape of hemoglobinopathy and pulmonary vascular disease treatment.
Research Focus
Key Achievements
Top Papers
- 1